The efficacy of Yiqi Huoxue method in treating coronary artery disease after percutaneous coronary intervention: A meta-analysis in accordance with PRISMA guideline
机构：[1]Shenzhen Second People’s Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong Province, P.R. China,深圳市第二人民医院深圳医学信息中心[2]Department of Cardiovascular Disease, Beijing Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, P.R. China,[3]Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, P.R. China,[4]Graduate School, Gansu University of Chinese Medicine, Lanzhou, Gansu, P.R. China.
Background: Percutaneous coronary intervention (PCI), the most common method in treating coronary artery disease (CAD), has a variety of side effects. Yiqi Huoxue therapy (YQHX) can effectively alleviate the symptoms of patients and reduce the side effects. However, a reliable and systematic assessment of the methodologies is not available. Methods: Seven electronic databases were searched to identify randomized controlled trials of YQHX method for CAD after PCI. The quality assessment of the trials included was performed by employing the Cochrane Risk of Bias tool. Results: One thousand eight hundred sixty-eight patients from 23 randomized controlled trials were included in this review. The aggregated results showed that the experimental group got better effect in increasing ORR, TCMSRR, ECG, HDL-C, and in lowering the level of CRP, TC, and MACE in comparison with the control group. Conclusion: YQHX method is a valid complementary and alternative therapy in the management of CAD after PCI, and is an effective and safe therapy for CAD.
基金：
National Natural Science Foundation of China [82104770]; National Key R&D Program of China [2017YFC1700301]; Sanming Project of Medicine in Shenzhen [SZSM201612049]
第一作者机构：[1]Shenzhen Second People’s Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong Province, P.R. China,[2]Department of Cardiovascular Disease, Beijing Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, P.R. China,
共同第一作者：
通讯作者：
通讯机构：[2]Department of Cardiovascular Disease, Beijing Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, P.R. China,[*1]Department of Cardiovascular Disease, Beijing Xiyuan Hospital, China Academy of Chinese Medical Sciences, Building Xingyuan,No. 1 Xiyuan Caochang, Beijing 100091, P.R. China
推荐引用方式(GB/T 7714)：
Zhang Miao,Sun Ming-Yue,Chen Qi-Ting,et al.The efficacy of Yiqi Huoxue method in treating coronary artery disease after percutaneous coronary intervention: A meta-analysis in accordance with PRISMA guideline[J].MEDICINE.2022,101(41):doi:10.1097/MD.0000000000030739.
APA：
Zhang, Miao,Sun, Ming-Yue,Chen, Qi-Ting,Xu, Feng-Qin,Chen, Zong-Zheng...&Yin, Hui-Jun.(2022).The efficacy of Yiqi Huoxue method in treating coronary artery disease after percutaneous coronary intervention: A meta-analysis in accordance with PRISMA guideline.MEDICINE,101,(41)
MLA：
Zhang, Miao,et al."The efficacy of Yiqi Huoxue method in treating coronary artery disease after percutaneous coronary intervention: A meta-analysis in accordance with PRISMA guideline".MEDICINE 101..41(2022)
